Documents
Improving Selectivity for Intact Mass Spectrometry of Biotherapeutic mAbs
In this application, the baseline separation on the bioZen WidePore C4 column avoids any spectral overlap in the MS detector. And in the case of NIST mAb analysis, the stationary phase of the bioZen WidePore C4 provides the necessary separation relative to the BIOShell IgG C4.
Improving Selectivity for Intact Mass Spectrometry of Biotherapeutic mAbs
In this application, the baseline separation on the bioZen WidePore C4 column avoids any spectral overlap in the MS detector. And in the case of NIST mAb analysis, the stationary phase of the bioZen WidePore C4 provides the necessary separation relative to the BIOShell IgG C4.
Document Type:
Technical Notes
Separation Modes:
Reversed Phase
Phases: